Banks pushing All Ords to New High

Published 29-APR-2019 09:50 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Last week the All Ordinaries Index looked set to close as its highest level since December 2007, as the market continued to rally.

While the Materials sector has slowed, gaining just 0.5% in the past week, the Financials sector has risen nearly 2.5%. The big 4 banks, led by Westpac, which is up around 3%, is pushing the market higher, while AMP further strengthened the sector as it was up over 3%.

The last time the All Ordinaries Index traded above 6,500 points was over 11 years ago on the 17 December 2007, which was the start of the decline into the GFC. As mentioned previously, for the market to rise both the Material and Financial sectors need to move together, which they have done in recent weeks with Materials rising over 15%, while Financials are up over 10% for the year.

Again these two sectors are key to the market making strong gains this year and they will pull other sectors with them as the market mood becomes more bullish.



Over the last three decades, April has been a top performing month in the calendar year and over the past 5 years has averaged a gain of 1.58%. Historically, June has been the worst performing month with the All Ordinaries Index averaging a decline of 1.4%. This suggests the current bull run may end soon with the market likely to fall away into June.

Looking at the sectors, Information Technology was the best performer up around 4% followed by Utilities and Consumer Discretionary, both up around 3%. Materials and Communication Services were the worst performers as both were just barely in positive territory.

Of the top 200 stocks, Bellamy’s led the charge up over 18% and Eclipx Group was up nearly 15% followed by Appen and Breville both up around 7%. The worst performers were Galaxy Resources down over 5%, and Northern Star and Spotless down around 4%.

As I indicated in my last report, volatility has been very low, which can signal a change in trend. Last week, volatility was up by around 5.5%, and with reporting season upon us this adds weight to my reasoning as to why we need to be prepared for the market to turn sometime soon.


So what do we expect in the market?
The old saying to make hay while the sun shines rings true right now because while the All Ordinaries Index is bullish, we need to stay with it to reap the benefits.

That said, any new opportunities should be considered carefully, as the market is getting very close to heavy resistance from its previous all-time high in 2007 at 6,873 points.

In fact, the market is less than 6% away from this level. Therefore, while the market may rise for another two to four weeks I recommend investors exercise caution, as it is highly likely to fall into a low in late June or early July.


Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also author of Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in book stores and online at www.wealthwithin.com.au



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X